Olerup SSP Aktiebolag – Trademark Portfolio

Entity Type: 99

Olerup SSP Aktiebolag holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include XM-ONE.

Franzéngatan 5, 2 tr

SE-112 51 Stockholm

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

QTYPE
QTYPE
Pending 2015
XM-ONE
XM-ONE
Registered 2004

Trademark Classifications

Olerup SSP Aktiebolag's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Olerup SSP Aktiebolag have?

Olerup SSP Aktiebolag has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does Olerup SSP Aktiebolag file in?

Olerup SSP Aktiebolag files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Olerup SSP Aktiebolag's most well-known trademarks?

Olerup SSP Aktiebolag's registered trademark portfolio includes well-known marks such as XM-ONE. These are among 1 currently registered trademark in the portfolio.

What is Olerup SSP Aktiebolag's trademark registration success rate?

Olerup SSP Aktiebolag has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.